Marshall Wace’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$9.41M Sell
2024
Q2
$51M Buy
2024
Q1
$37.7M Sell
2023
Q4
$50.8M Buy
2023
Q3
$14.8M Buy
2023
Q2
$9.82M Sell
2023
Q1
$12M Sell
2022
Q4
$29.7M Buy
2022
Q3
$18.3M Buy
2022
Q2
$539K Buy
2021
Q2
Sell
2021
Q1
$423K Buy
2020
Q4
$211K Buy
2015
Q4
Sell
2015
Q3
$1.14M Buy